Study to Evaulate the Kappa Opioid Receptor as a Target for the Treatment of Mood and Anxiety Spectrum Disorders by Evaluating Whether LY2456302 Engages Reward-related Neural Circuitry.

Administered By

Awarded By

Contributors

Start/End

  • August 29, 2013 - December 31, 2017